Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Contraception and Contraceptive Drugs

Free Subscription Articles published in Am J Obstet Gynecol Retrieve available abstracts of 70 articles: HTML format

Single Articles

May 2024
1. AMES JL, Anderson MC, Cronbach E, Lee C, et al
   Reproductive healthcare in adolescents with autism and other developmental disabilities.
   Am J Obstet Gynecol. 2024;230:546.
   PubMed     Abstract available
   
   
   April 2024
2. LO FARO V, Johansson A
   Genotyping oral contraceptive users for venous thromboembolism risk.
   Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00565.
   PubMed    
   
   
   
3. VERCELLINI P, Artoni A, Abbattista M, Martinelli I, et al
   PREDICTION OF VENOUS THROMBOEMBOLISM IN AVERAGE-RISK YOUNG CANDIDATES FOR ORAL CONTRACEPTIVE USE: TO GENOTYPE, OR NOT TO GENOTYPE, THAT IS THE QUESTION.
   Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00564.
   PubMed    
   
   
   March 2024
4. MATOVINA CN, Sakowicz A, Allen EC, Alvarado-Goldberg MI, et al
   The association between postpartum depressive symptoms and contraception.
   Am J Obstet Gynecol. 2024 Mar 27:S0002-9378(24)00472.
   PubMed     Abstract available
   
   
   
5. SANCHEZ-RAMOS L, Levine LD, Sciscione AC, Mozurkewich EL, et al
   Methods for the induction of labor: efficacy and safety.
   Am J Obstet Gynecol. 2024;230.
   PubMed     Abstract available
   
   
   February 2024
6. TORRES E, Carter G, Gero A, Simmons RG, et al
   Frequency of same-day start contraceptive initiation, recent unprotected intercourse, and pregnancy risk: a prospective cohort study of multiple contraceptive methods.
   Am J Obstet Gynecol. 2024 Feb 15:S0002-9378(24)00083.
   PubMed     Abstract available
   
   
   January 2024
7. PLAGIANOS MG, Ramanadhan S, Merkatz RB, Brache V, et al
   Risk Factors for and Outcomes of Ring Expulsions with a One Year Contraceptive Vaginal System.
   Am J Obstet Gynecol. 2024 Jan 29:S0002-9378(24)00061.
   PubMed     Abstract available
   
   
   
8. HUIJS DPC, Derickx AJM, Beelen P, Leemans JC, et al
   A 52 mg levonorgestrel-releasing intrauterine system versus bipolar radiofrequency non-resectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multi-center randomized controlled trial.
   Am J Obstet Gynecol. 2024 Jan 25:S0002-9378(24)00045.
   PubMed     Abstract available
   
   
   December 2023
9. GUO XM, Lim LM, Matsuzaki S, Matsuo K, et al
   Research on intrauterine manipulators for endometrial cancer: Attention to study-level characteristics.
   Am J Obstet Gynecol. 2023 Dec 8:S0002-9378(23)02122.
   PubMed    
   
   
   October 2023
10. DANVERS AA, Gurney EG, Panushka K, Peskin M, et al
    Shortcomings and Disparities in Contraception Counseling and Use by Hypertensive Individuals at Risk for Unintended Pregnancy: A Comparative Analysis of the National Survey of Family Growth 2015-2019.
    Am J Obstet Gynecol. 2023 Oct 21:S0002-9378(23)00768.
    PubMed     Abstract available
    
    
    September 2023
11. LO FARO V, Johansson T, Johansson A
    The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
    Am J Obstet Gynecol. 2023 Sep 19:S0002-9378(23)00618.
    PubMed     Abstract available
    
    
    August 2023
12. MATTESON KA, Valcin J, Raker CA, Clark MA, et al
    A randomized trial comparing the 52-mg levonorgestrel system to combination oral contraceptives for treatment of heavy menstrual bleeding.
    Am J Obstet Gynecol. 2023 Aug 1:S0002-9378(23)00521.
    PubMed     Abstract available
    
    
    July 2023
13. EASTIN EF, Nelson DA, Shaw JG, Shaw KA, et al
    Postpartum long-acting reversible contraceptive use among active-duty, female U.S. Army soldiers.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00471.
    PubMed     Abstract available
    
    
    
14. CATHCART AM, Nezhat FR, Fitch KC, Nguyen CGT, et al
    Trends in permanent contraceptive procedural volume in the United States between 2019 and 2020.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00467.
    PubMed    
    
    
    
15. CREININ MD, Jensen JT
    Extending use of levonorgestrel 52 mg intrauterine device to 8 years.
    Am J Obstet Gynecol. 2023;229:84.
    PubMed    
    
    
    
16. GOLDBERG AB
    Extending the use of levonorgestrel 52 mg intrauterine devices to 8 years.
    Am J Obstet Gynecol. 2023;229:85.
    PubMed    
    
    
    June 2023
17. SWAN LET, Cutler AS, Higgins JA
    Response to Letter to the Editor Regarding Physician Beliefs about Contraceptives as Abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00412.
    PubMed    
    
    
    
18. BEITER KA, Stanford JB
    Contraceptives as abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00411.
    PubMed    
    
    
    April 2023
19. EDELMAN A, Boniface E, Schrote K, Messerle-Forbes M, et al
    Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00265.
    PubMed     Abstract available
    
    
    March 2023
20. PHILLIPS AM, Rachad S, Flink-Bochacki R
    The association between abortion restrictions and patient-centered care for early pregnancy loss at U.S. OB/GYN residency programs.
    Am J Obstet Gynecol. 2023 Mar 30:S0002-9378(23)00223.
    PubMed     Abstract available
    
    
    
21. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    PubMed     Abstract available
    
    
    
22. ZHANG J, Zhu C, Yan L, Wang Y, et al
    Comparing levonorgestrel intrauterine system versus hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open label, controlled trial.
    Am J Obstet Gynecol. 2023 Mar 17:S0002-9378(23)00167.
    PubMed     Abstract available
    
    
    
23. LEVINE EM
    Extended use of the Levonorgestrel Intrauterine System for Contraception.
    Am J Obstet Gynecol. 2023 Mar 16:S0002-9378(23)00160.
    PubMed    
    
    
    
24. THURMAN AR, Moench TR, Hoke M, Politch JA, et al
    ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Am J Obstet Gynecol. 2023 Mar 2:S0002-9378(23)00139.
    PubMed     Abstract available
    
    
    February 2023
25. RODRIGUEZ MI, Meath T, Watson K, Daly A, et al
    Predicted changes in travel distance for abortion among counties with low rates of effective contraceptive use following Dobbs v Jackson.
    Am J Obstet Gynecol. 2023 Feb 2:S0002-9378(23)00072.
    PubMed    
    
    
    December 2022
26. MCCOLL R, Gifford K, Joan McDuffie M, Boudreaux M, et al
    Same-day long-acting reversible contraceptive utilization after a statewide contraceptive access initiative.
    Am J Obstet Gynecol. 2022 Dec 21:S0002-9378(22)02582.
    PubMed     Abstract available
    
    
    
27. HEALY A, Davidson C, Allbert J, Bauer S, et al
    Telemedicine in obstetrics, quality and safety considerations.
    Am J Obstet Gynecol. 2022 Dec 5:S0002-9378(22)02261.
    PubMed     Abstract available
    
    
    November 2022
28. KAISER JE, Turok DK, Gero A, Gawron LM, et al
    One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: A randomized controlled trial.
    Am J Obstet Gynecol. 2022 Nov 22:S0002-9378(22)02189.
    PubMed     Abstract available
    
    
    October 2022
29. FELS LM, Costescu D, Vieira CS, Peipert JF, et al
    The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    Am J Obstet Gynecol. 2022 Oct 29:S0002-9378(22)00835.
    PubMed     Abstract available
    
    
    September 2022
30. SWAN LET, Cutler AS, Lands M, Schmuhl NB, et al
    Physician Beliefs about Contraceptive Methods as Abortifacients.
    Am J Obstet Gynecol. 2022 Sep 28. pii: S0002-9378(22)00772.
    PubMed    
    
    
    
31. JENSEN JT, Lukkari-Lax E, Schulze A, Wahdan Y, et al
    Contraceptive efficacy and safety of 52mg LNG-IUS for up to 8 years: findings from the Mirena Extension Trial.
    Am J Obstet Gynecol. 2022 Sep 9. pii: S0002-9378(22)00729.
    PubMed     Abstract available
    
    
    August 2022
32. HOGMARK S, Lichtenstein Liljeblad K, Envall N, Gemzell-Danielsson K, et al
    Placement of an intrauterine device within 48 hours after early medical abortion - a randomized controlled trial.
    Am J Obstet Gynecol. 2022 Aug 12. pii: S0002-9378(22)00646.
    PubMed     Abstract available
    
    
    
33. HENKEL A, Lerma K, Reyes G, Gutow H, et al
    Lactogenesis and breastfeeding after immediate versus delayed birth-hospitalization insertion of etonogestrel contraceptive implant: A non-inferiority trial.
    Am J Obstet Gynecol. 2022 Aug 11. pii: S0002-9378(22)00644.
    PubMed     Abstract available
    
    
    July 2022
34. MILLER R, Gyamfi-Bannerman C
    Society for Maternal-Fetal Medicine Consult Series #63: Cesarean scar ectopic pregnancy.
    Am J Obstet Gynecol. 2022 Jul 15. pii: S0002-9378(22)00478.
    PubMed     Abstract available
    
    
    June 2022
35. NAGENDRA D, Gutman SM, Koelper NC, Loza-Avalos SE, et al
    Medical management of early pregnancy loss is cost-effective compared to office uterine aspiration.
    Am J Obstet Gynecol. 2022 Jun 30. pii: S0002-9378(22)00530.
    PubMed     Abstract available
    
    
    
36. GOUETH RC, Maki KG, Babatunde A, Eden KB, et al
    Effects of Technology-Based Contraceptive Decision Aids: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2022 Jun 29. pii: S0002-9378(22)00526.
    PubMed     Abstract available
    
    
    
37. TOFFOL E, Heikinheimo O, Jousilahti P, But A, et al
    Metabolomics profile of 5649 users and non-users of hormonal intrauterine devices in Finland.
    Am J Obstet Gynecol. 2022 Jun 10. pii: S0002-9378(22)00455.
    PubMed     Abstract available
    
    
    
38. VAN BIEMA F, Friedman AM, Cepin AG, Wen T, et al
    Trends in Use of Long-Acting Reversible Contraception during Delivery Hospitalizations, 2000-2019.
    Am J Obstet Gynecol. 2022 Jun 3. pii: S0002-9378(22)00436.
    PubMed    
    
    
    May 2022
39. FANG NZ, Westhoff CL
    Update on Incidence of Inpatient Tubal Ligation and Long-acting Reversible Contraception in the United States.
    Am J Obstet Gynecol. 2022 May 12. pii: S0002-9378(22)00365.
    PubMed     Abstract available
    
    
    
40. CREININ MD, Schreiber CA, Turok DK, Cwiak C, et al
    Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.
    Am J Obstet Gynecol. 2022 May 12. pii: S0002-9378(22)00366.
    PubMed     Abstract available
    
    
    April 2022
41. GATZ JL, Armstrong MA, Postlethwaite D, Raine-Bennett T, et al
    Association Between Intrauterine Device Type and Risk of Perforation and Device Expulsion: Results From the APEX-IUD Study.
    Am J Obstet Gynecol. 2022 Apr 5. pii: S0002-9378(22)00264.
    PubMed    
    
    
    March 2022
42. MONIZ MH, Peahl AF, Dawn Zinsser M, Kolenic MGE, et al
    Social Vulnerability and Utilization of Postpartum Long-acting Reversible Contraception and Sterilization.
    Am J Obstet Gynecol. 2022 Mar 18. pii: S0002-9378(22)00202.
    PubMed    
    
    
    
43. GETAHUN D, Fassett MJ, Gatz J, Armstrong MA, et al
    Association Between Menorrhagia and Risk of Intrauterine Device-Related Uterine Perforation and Device Expulsion: Results from the APEX-IUD Study.
    Am J Obstet Gynecol. 2022 Mar 12. pii: S0002-9378(22)00197.
    PubMed     Abstract available
    
    
    
44. THORNTON M, Ascha MS, Arora KS
    Addressing Fluidity in Contraceptive Decision-Making: A Key Component of Patient-Centered Contraceptive Counseling.
    Am J Obstet Gynecol. 2022 Mar 3. pii: S0002-9378(22)00160.
    PubMed    
    
    
    December 2021
45. FANG NZ, Advaney SP, Castano PM, Davis A, et al
    Female Permanent Contraception Trends and Updates.
    Am J Obstet Gynecol. 2021 Dec 29. pii: S0002-9378(21)02956.
    PubMed     Abstract available
    
    
    
46. RALPH LJ, Ehrenreich K, Barar R, Biggs MA, et al
    Accuracy of self-assessment of gestational duration among people seeking abortion.
    Am J Obstet Gynecol. 2021 Dec 16. pii: S0002-9378(21)02683.
    PubMed     Abstract available
    
    
    
47. BURCHARDT NA, Eliassen AH, Shafrir AL, Rosner B, et al
    Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
    Am J Obstet Gynecol. 2021 Dec 15. pii: S0002-9378(21)02686.
    PubMed     Abstract available
    
    
    October 2021
48. KRAMER RD, Higgins JA, Everett B, Turok DK, et al
    A Prospective Analysis of the Relationship Between Sexual Acceptability and Contraceptive Satisfaction Over Time.
    Am J Obstet Gynecol. 2021 Oct 14. pii: S0002-9378(21)01109.
    PubMed     Abstract available
    
    
    
49. MONIZ MH, Dalton VK, Smith RD, Owens LE, et al
    Feasibility and Acceptability of a Toolkit-Based Process to Implement Patient-Centered, Immediate Postpartum Long-Acting Reversible Contraception Services.
    Am J Obstet Gynecol. 2021 Oct 13. pii: S0002-9378(21)01110.
    PubMed     Abstract available
    
    
    
50. HESTER RH, Hortobagyi GN, Lim B
    Inflammatory breast cancer: early recognition and diagnosis is critical.
    Am J Obstet Gynecol. 2021;225:392-396.
    PubMed     Abstract available
    
    
    August 2021
51. CHEN C, Strasser J, Banawa R, Luo Q, et al
    Who is providing contraception care in the United States? An Observational Study of the Contraception Workforce.
    Am J Obstet Gynecol. 2021 Aug 18. pii: S0002-9378(21)00883.
    PubMed     Abstract available
    
    
    July 2021
52. DE WIT AE, DE Vries YA, DE Boer MK, Scheper C, et al
    Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials.
    Am J Obstet Gynecol. 2021 Jul 2. pii: S0002-9378(21)00774.
    PubMed     Abstract available
    
    
    
53. RODRIGUEZ MI, Skye M, Edelman AB, Anderson L, et al
    Association of pharmacist prescription and 12 month contraceptive continuation rates.
    Am J Obstet Gynecol. 2021 Jul 1. pii: S0002-9378(21)00773.
    PubMed     Abstract available
    
    
    June 2021
54. HARITON E, Shirazi TN, Douglas NC, Hershlag A, et al
    Anti-Mullerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals.
    Am J Obstet Gynecol. 2021 Jun 11. pii: S0002-9378(21)00685.
    PubMed     Abstract available
    
    
    April 2021
55. KAIMAL A, Norton ME
    Society for Maternal-Fetal Medicine Consult Series #55: Counseling women at increased risk of maternal morbidity and mortality.
    Am J Obstet Gynecol. 2021;224:B16-B23.
    PubMed     Abstract available
    
    
    
56. YEE LM, Williams B, Green HM, Carmona-Barrera V, et al
    Bridging the postpartum gap: Best practices for training of obstetric patient navigators.
    Am J Obstet Gynecol. 2021 Apr 1. pii: S0002-9378(21)00218.
    PubMed     Abstract available
    
    
    March 2021
57. MILLS K, Marchand G, Sainz K, Azadi A, et al
    Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2021;224:258-265.
    PubMed     Abstract available
    
    
    January 2021
58. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    PubMed     Abstract available
    
    
    December 2020
59. MERZ AA, Gutierrez-Sacristan A, Bartz D, Williams NE, et al
    Population attitudes toward contraceptive methods over time on a social media platform.
    Am J Obstet Gynecol. 2020 Dec 9. pii: S0002-9378(20)31378.
    PubMed     Abstract available
    
    
    
60. RUSSELL CB, Evans ML, Qasba N, Frankel A, et al
    Medicaid sterilization consent forms: variation in rejection and payment consequences.
    Am J Obstet Gynecol. 2020;223:934-936.
    PubMed    
    
    
    November 2020
61. GO VAA, Thomas MC, Singh B, Prenatt S, et al
    A systematic review of the psychosocial impact of fibroids before and after treatment.
    Am J Obstet Gynecol. 2020;223:674-708.
    PubMed     Abstract available
    
    
    October 2020
62. JOULAUD P, Pithois A, Ramanah R
    VAGINAL BLEEDING FROM AN UNIDENTIFIED SUSPICIOUS UTERINE TUMOR IN A YOUNG WOMAN.
    Am J Obstet Gynecol. 2020 Oct 13. pii: S0002-9378(20)31185.
    PubMed    
    
    
    
63. SCHULTHEIS P, Natalie Montoya M, Zhao Q, Archer J, et al
    Contraception and Ectopic Pregnancy Risk: A Prospective Observational Analysis.
    Am J Obstet Gynecol. 2020 Oct 10. pii: S0002-9378(20)31187.
    PubMed     Abstract available
    
    
    
64. CHUNG YS, Woo HY, Lee JY, Park E, et al
    Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
    Am J Obstet Gynecol. 2020 Oct 8. pii: S0002-9378(20)31175.
    PubMed     Abstract available
    
    
    September 2020
65. BEDFORD L, Parker SE, Davis E, Salzman E, et al
    Characteristics of the vaginal microbiome in women with and without clinically confirmed vulvodynia.
    Am J Obstet Gynecol. 2020;223:406.
    PubMed     Abstract available
    
    
    
66. SONG X, Wu J, Zhou Y, Feng L, et al
    Reproductive and hormonal factors and risk of cognitive impairment among Singapore Chinese women.
    Am J Obstet Gynecol. 2020;223:410.
    PubMed     Abstract available
    
    
    August 2020
67. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    PubMed     Abstract available
    
    
    
68. BEELEN P, VAN DEN Brink MJ, Herman MC, Geomini PM, et al
    Levonorgestrel releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
    Am J Obstet Gynecol. 2020 Aug 11. pii: S0002-9378(20)30844.
    PubMed     Abstract available
    
    
    April 2020
69. SONALKAR S, Koelper N, Creinin MD, Atrio JM, et al
    Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial.
    Am J Obstet Gynecol. 2020 Apr 16. pii: S0002-9378(20)30431.
    PubMed     Abstract available
    
    
    January 2020
70. MILLER R, Timor IE, Gyamfi-Bannerman C
    Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy.
    Am J Obstet Gynecol. 2020 Jan 20. pii: S0002-9378(20)30038.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.